Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2)

dexamethasone cyclodextrin nanoparticle ophthalmic suspension (OCS-01) - Oculis

Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema (DIAMOND-2) (clinicaltrials.gov) - Dec 15, 2023 - P3 | N=350 | Not yet recruiting | Sponsor: Oculis
New P3 trial • Diabetic Macular Edema • Ophthalmology

http://clinicaltrials.gov/ct2/show/NCT06172257

Dec 15, 2023